User profiles for ATSUNARI KAWASHIMA
Atsunari KawashimaDepartment of Urology, Osaka University Verified email at uro.med.osaka-u.ac.jp Cited by 3028 |
CCR8-targeted specific depletion of clonally expanded Treg cells in tumor tissues evokes potent tumor immunity with long-lasting memory
…, Y Yasumizu, A Kawashima… - Proceedings of the …, 2022 - National Acad Sciences
Foxp3-expressing CD25 + CD4 + regulatory T cells (Tregs) are abundant in tumor tissues.
Here, hypothesizing that tumor Tregs would clonally expand after they are activated by tumor-…
Here, hypothesizing that tumor Tregs would clonally expand after they are activated by tumor-…
[HTML][HTML] Mutational landscape and environmental effects in bladder cancer
…, K Fujita, Y Hayashi, K Hatano, A Kawashima… - International journal of …, 2020 - mdpi.com
Bladder cancer is the most common cancer of the urinary tract. Although nonmuscle-invasive
bladder cancers have a good prognosis, muscle-invasive bladder cancers promote …
bladder cancers have a good prognosis, muscle-invasive bladder cancers promote …
Infiltration of tumour-associated macrophages in prostate biopsy specimens is predictive of disease progression after hormonal therapy for prostate cancer.
…, M Nakayama, Y Nakai, A Kawashima… - BJU …, 2011 - search.ebscohost.com
OBJECTIVE• To evaluate tumour-associated macrophage (TAM) infiltration in prostate biopsy
specimens as a possible prognostic factor for prostate cancer (PCa) after hormonal therapy…
specimens as a possible prognostic factor for prostate cancer (PCa) after hormonal therapy…
Gut microbiota–derived short-chain fatty acids promote prostate cancer growth via IGF1 signaling
…, C Wang, Y Ishizuya, T Kato, K Hatano, A Kawashima… - Cancer research, 2021 - AACR
These results suggest that intestinal bacteria, acting through short-chain fatty acids, regulate
systemic and local prostate IGF1 in the host, which can promote proliferation of prostate …
systemic and local prostate IGF1 in the host, which can promote proliferation of prostate …
[HTML][HTML] Proteomic analysis of urinary extracellular vesicles from high Gleason score prostate cancer
K Fujita, H Kume, K Matsuzaki, A Kawashima, T Ujike… - Scientific reports, 2017 - nature.com
Extracellular vesicles (EVs) are microvesicles secreted from various cell types. We aimed to
discover a new biomarker for high Gleason score (GS) prostate cancer (PCa) in urinary EVs …
discover a new biomarker for high Gleason score (GS) prostate cancer (PCa) in urinary EVs …
High-fat diet-induced inflammation accelerates prostate cancer growth via IL6 signaling
…, K Matsuzaki, K Jingushi, T Kato, A Kawashima… - Clinical Cancer …, 2018 - AACR
Purpose: High-fat diet (HFD) could induce prostate cancer progression. The aim of this
study is to identify mechanisms of HFD-induced prostate cancer progression, focusing on …
study is to identify mechanisms of HFD-induced prostate cancer progression, focusing on …
Summary of the clinical practice guidelines for upper tract urothelial carcinoma 2023 by the Japanese Urological Association
…, T Hara, Y Matsushita, A Kawashima… - … Journal of Urology, 2024 - Wiley Online Library
This article is an English translation of the Clinical Practice Guidelines for Upper Tract
Urothelial Carcinoma (2nd edition) published in June 2023. The Japanese Urological …
Urothelial Carcinoma (2nd edition) published in June 2023. The Japanese Urological …
ICOS+ Foxp3+ TILs in gastric cancer are prognostic markers and effector regulatory T cells associated with Helicobacter pylori
…, A Morimoto‐Okazawa, A Kawashima… - … journal of cancer, 2017 - Wiley Online Library
Regulatory T cells (Tregs) have an immunosuppressive role in the tumor microenvironment.
Since effector Tregs (eTregs), which have highly suppressive functions, are located in a …
Since effector Tregs (eTregs), which have highly suppressive functions, are located in a …
[HTML][HTML] Comparison of molecular profiles of upper tract urothelial carcinoma vs. urinary bladder cancer in the era of targeted therapy: a narrative review
…, M Hashimoto, S Adomi, A Kawashima… - Translational …, 2022 - ncbi.nlm.nih.gov
Methods This narrative review summarized the subgroup analyses of clinical trials of FDA-approved
targeted drugs to explore the differential effects of each targeted drug when …
targeted drugs to explore the differential effects of each targeted drug when …
High-dose-rate brachytherapy as monotherapy for intermediate-and high-risk prostate cancer: clinical results for a median 8-year follow-up
…, K Fujita, A Nagahara, T Ujike, A Kawashima… - International Journal of …, 2016 - Elsevier
Purpose To present mature results of high-dose-rate brachytherapy (HDR-BT) as monotherapy
for intermediate- and high-risk prostate cancer. Methods and Materials From 1995 …
for intermediate- and high-risk prostate cancer. Methods and Materials From 1995 …